Biosimilar Post-Approval Change Guidance Coming From US FDA

 
• By Derrick Gingery
  
Binoculars hang on a wooden fence background
Biosimilar sponsors' postmarket responsibilities may be coming into more focus.

More from Manufacturing

More from Compliance